New Separations for MALDI-TOF Mass Spectrometry

Information

  • Research Project
  • 7822757
  • ApplicationId
    7822757
  • Core Project Number
    R44GM079833
  • Full Project Number
    5R44GM079833-03
  • Serial Number
    79833
  • FOA Number
    PA-08-050
  • Sub Project Id
  • Project Start Date
    3/1/2007 - 17 years ago
  • Project End Date
    4/30/2011 - 13 years ago
  • Program Officer Name
    EDMONDS, CHARLES G.
  • Budget Start Date
    5/1/2010 - 14 years ago
  • Budget End Date
    4/30/2011 - 13 years ago
  • Fiscal Year
    2010
  • Support Year
    3
  • Suffix
  • Award Notice Date
    4/28/2010 - 14 years ago

New Separations for MALDI-TOF Mass Spectrometry

DESCRIPTION (provided by applicant): The ultimate goal of this research is to provide integrated systems that allow complex biological samples to be analyzed with high sensitivity and broad dynamic range. These systems are applicable to proteins, DNA and RNA oligomers, and metabolites from bodily fluids and tissues. This project is specifically focused on developing novel sample plates employing collimated hole structures that allow a variety of separation techniques to be efficiently coupled to MALDI-TOF and TOF-TOF mass spectrometry. Phase I established the basic feasibility of the new MALDI plates for interfacing with several widely used separation techniques including HPLC and slab gel electrophoresis, and with direct imaging of frozen tissue sections. Phase II will produce a new family of MALDI sample plates optimized for these applications and devices for interfacing with a variety of techniques for efficiently separating peptides, proteins, and metabolites. These devices integrated with new MALDI-TOF MS and MS-MS instruments being developed in parallel projects will provide orders of magnitude improvements in capabilities for global analysis of complex biological samples. Specific aims for Phase II are focused on practical MALDI sample plates employing collimated hole structures optimized for selected applications, and on practical devices for interfacing MALDI MS and MS- MS with established techniques for efficiently separating peptides, proteins, and metabolites. The definition of a practical CHS plate for these applications is that it must be sufficiently inexpensive to be disposable after single use, or there must be a simple, reliable procedure for cleaning the plates with no detectable sample carry-over. These new MALDI sample plates, parallel digestion plates, and the apparatus and reagents required for their use will provide important new products for commercialization in Phase III. In addition, complete integrated systems combining output of this project with results from other projects being pursued concurrently at Virgin Instruments Corp. will provide products with much larger potential markets. These include a fully automated LC-MALDI MS-MS system for global biological analyses;an automated "Molecular Scanner" for protein analyses using gels and MALDI MS and MS-MS;integrated global analysis laboratory;and an automated high-speed tissue imager. PUBLIC HEALTH RELEVANCE: The human genome project has established the molecular approach to understanding biology, but present knowledge of how an organism functions at the molecular level is really very poor. Functional analyses must be carried out, not only at the level of gene expression (transcriptomics), but also at the level of protein translation and modification (proteomics), and the metabolite network (metabolomics). Further improvements in chemistry, separations science, mass spectrometry, and bio-informatics will be required to complete this revolution. The interface between separations and mass spectrometry is believed to be a major bottleneck. The proposed research will provide important new tools toward overcoming this obstacle.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    375000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:375000\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    VIRGIN INSTRUMENTS CORPORATION
  • Organization Department
  • Organization DUNS
    606001134
  • Organization City
    SUDBURY
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    017760818
  • Organization District
    UNITED STATES